Article Text

Download PDFPDF
First approved treatment in children with multiple sclerosis slows brain atrophy

Statistics from Altmetric.com

Footnotes

  • Twitter @es_arman

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests I have received funding for travel from the US National Multiple Sclerosis Society, speaker’s honorarium (paid to my institution) from Biogen and At The Limits educational programme.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles